We are happy to inform that we have obtained the MA for our Pirfenidone 267 and 801mg Film-coated Tablets in France, through DCP DE/H/7564/01-02/DC. This MA shall be available for transfer to our partners. Pirfenidone is used for treatment in adults with idiopathic pulmonary fibrosis (IPF). Please note that we have also developed Pirfenidone hard capsules dossier, and it is ready for filing. Feel free to contact our team for further information.
